SMS Pharmaceuticals LtdPharmaceuticalsINE812G01025Consolidated₹525.50+11.35 (+2.21%)
Valuation
Market Cap₹4.92K Cr
TTM PE41.51x
Forward PE39.14x
PEG3.29
Book Value₹83.91
P/B6.26x
TTM EPS₹12.66
Fwd EPS₹13.43
TTM Revenue₹971.45 Cr
TTM PAT₹116.94 Cr
TTM EBITDA₹192.16 Cr
TTM EBIT₹151.58 Cr
Last Qtr PAT₹39.85 Cr
Last Qtr EBITDA₹67.66 Cr
Last Qtr EBIT₹57.22 Cr
Profitability
ROE14.88%
ROCE13.99%
TTM NPM12.04%
TTM EBITDA %19.78%
Curr OPM12.55%
Last OPM10.02%
Curr NPM—
Last NPM—
Curr EPS₹4.26
Last EPS₹2.23
Balance sheet
Equity₹9.37 Cr
Reserve₹776.44 Cr
Total Debt₹365.05 Cr
D/E0.46x
Interest %14.40%
Curr Interest₹5.74 Cr
Price / range
Close₹525.50
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+2.21%
1W+10.53%
1M+11.50%
3M+44.57%
6M+29.39%
1Y+86.74%
2Y+78.23%
3Y+339.01%
5Y+288.97%
Diwali+67.84%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue316.07+30.4%206.96237.95210.45242.43886.87
Other Income1.341.742.573.751.438.35
Total Income317.41+30.2%208.71240.52214.20243.86895.22
Interest26.925.505.286.225.7423.08
Expenditure-264.89-26.3%-180.57-213.48-182.89-209.81-778.95
PBDT000000
EBITDA83.84+73.3%41.8839.8843.8048.38170.92
Depreciation-5.74-9.99-10.13-10.02-10.02-39.92
EBIT78.10+103.6%31.8929.7533.7838.36131
PBT52.53+54.2%28.1427.0531.3134.06116.27
Tax-13.39-7.01-6.12-7.97-8.91-28.66
Equity9.379.379.37009.37
OPM16.5513.4811.2514.8814.0512.99
Net Profit39.13+55.6%21.1320.9223.3425.1487.61
NPM12.3310.128.7011.0910.379.79
EPS4.18+48.2%2.262.292.572.829.58

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue886.87+13.3%782.75+10.4%709.26+35.9%522.05+0.4%519.87-7.7%563.18
Other Income8.356.224.464.895.203.45
Total Income895.22+13.5%788.97+10.5%713.72+35.4%526.94+0.4%525.07-7.3%566.63
Expenditure-778.95-12.0%-695.65-7.5%-647.39-24.2%-521.39-14.2%-456.42+4.0%-475.51
Interest-23.08-18.54-23.46-21.92-18.88-11.16
PBDT000000
EBITDA170.92+22.1%139.98+19.8%116.85+113.6%54.71-52.2%114.48-5.5%121.11
Depreciation-39.92-34.34-31.52-32.13-32.15-22.28
EBIT131+24.0%105.64+23.8%85.33+277.9%22.58-72.6%82.33-16.7%98.83
PBT116.27+24.6%93.32+40.7%66.33+1095.1%5.55-91.9%68.66-24.6%91.12
Tax-28.66-24.94-16.91-1.47-0.62-30.16
Equity9.378.870000
OPM (%)12.9911.839.001.0013.0016.00
Net Profit87.61+28.1%68.38+38.3%49.43+1108.6%4.09-94.0%68.04+11.6%60.97
NPM (%)9.798.677.001.0013.0011.00
EPS (Rs)9.58+18.7%8.07+38.2%5.84+1116.7%0.48-94.0%8.04+11.7%7.20
CEPS9.588.075.840.488.047.20

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue316.09+30.4%206.96237.95210.45242.43886.87
Other Income1.341.742.573.751.438.35
Total Income317.43+30.2%208.71240.52214.20243.86895.22
Interest5.745.505.286.225.7423.08
Expenditure-264.61-26.1%-181.50-213.46-183.04-209.82-778.59
PBDT000000
EBITDA67.66+39.9%40.9539.9043.6548.37171.28
Depreciation-10.44-9.99-10.13-10.02-10.02-39.92
EBIT57.22+49.2%30.9629.7733.6338.35131.36
PBT52.82+55.2%27.2127.0731.1634.04116.64
Tax-13.25-7-6.10-7.97-8.91-28.64
Equity9.379.379.37009.37
OPM16.6413.0411.2514.5513.9613.03
Net Profit39.85+57.4%20.9132.7123.4725.31101.99
NPM12.5510.0213.6010.9610.3811.39
EPS4.26+50.0%2.233.582.592.8411.15

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue886.87+13.3%782.75+10.4%709.26+35.9%522.05+0.4%519.87-7.7%563.18
Other Income8.356.224.464.895.203.45
Total Income895.22+13.5%788.97+10.5%713.72+35.4%526.94+0.4%525.07-7.3%566.63
Expenditure-778.59-11.8%-696.64-7.6%-647.62-24.2%-521.59-14.2%-456.57+4.0%-475.51
Interest-23.08-18.54-23.46-21.92-18.88-11.16
PBDT000000
EBITDA171.28+23.2%138.99+19.2%116.62+113.9%54.51-52.3%114.33-5.6%121.11
Depreciation-39.92-34.34-31.52-32.13-32.15-22.28
EBIT131.36+25.5%104.65+23.0%85.10+280.3%22.38-72.8%82.18-16.8%98.83
PBT116.64+26.3%92.34+39.7%66.11+1135.7%5.35-92.2%68.50-24.8%91.12
Tax-28.64-24.94-16.91-1.47-0.62-30.16
Equity9.378.870000
OPM (%)13.0311.709.261.0213.0516.08
Net Profit101.99+47.5%69.14+38.8%49.83+805.8%-7.06-111.3%62.22-0.5%62.53
NPM (%)11.398.766.98-1.3411.8511.03
EPS (Rs)11.15+36.6%8.16+38.5%5.89+809.6%-0.83-111.3%7.35-0.5%7.39
CEPS11.158.165.8907.357.39

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

19
YearTypeAmountEx-Date
2026Final Dividend0.422 Sep 2026
2026Final Dividend0.416 Sep 2026
2025Final Dividend0.422 Sep 2025
2024Final Dividend0.423 Sep 2024
2023Final Dividend0.322 Sep 2023
2022Final Dividend0.322 Sep 2022
2021Final Dividend0.322 Sep 2021
2020Interim Dividend0.2526 Mar 2020
2019Final Dividend0.2519 Sep 2019
2018Final Dividend0.2511 Sep 2018
2017Final Dividend0.220 Sep 2017
2016Final Dividend0.222 Sep 2016
2015Final Dividend222 Sep 2015
2014Final Dividend223 Sep 2014
2013Final Dividend223 Sep 2013
2011Final Dividend1.522 Sep 2011
2010Final Dividend123 Sep 2010
2009Final Dividend223 Sep 2009
2008Final Dividend223 Dec 2008

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2015Rs.10/- to Rs.1/-17 Dec 2015
Loading company dashboard...
Fetching ratios, charts, and peers